Skip to main content
Advertisement
Advertisement
OGN
OGN logo
Organon & Co.
13.89
USD
Sponsored
-0.02
-0.14%
Nov 20, 15:45 UTC -5
Closed
exchange

After-Market

13.80

-0.09
-0.64%

Organon & Co. (OGN) Earnings

OGN Earnings Reports

Positive Surprise Ratio

OGN beat 15 of 23 last estimates.

65%

Next Report

Date of Next Report
Feb 10, 2027
Estimate for Q4 26 (Revenue/ EPS)
$1.56B
/
$0.79
Implied change from Q3 26 (Revenue/ EPS)
-1.12%
/
-15.96%
Implied change from Q4 25 (Revenue/ EPS)
+3.28%
/
+25.40%

Organon & Co. earnings per share and revenue

On Oct 30, 2026, OGN reported earnings of 0.94 USD per share (EPS) for Q3 26, missing the estimate of 0.94 USD, resulting in a -0.73% surprise. Revenue reached 1.57 billion, compared to an expected 1.59 billion, with a -1.03% difference. The market reacted with a +0.22% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.79 USD, with revenue projected to reach 1.56 billion USD, implying an decrease of -15.96% EPS, and decrease of -1.12% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Freenome, Inc. Common stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
$0.41
Actual
$0.57
Surprise
+38.69%
logo
SBC Medical Group Holdings Incorporated Common Stock
Report Date
Nov 13, 2026 For Q3 26
Estimate
$0.11
Actual
$0.15
Surprise
+32.63%
logo
Auna S.A.
Report Date
Nov 17, 2026 For Q3 26
Estimate
$0.85
Actual
$0.27
Surprise
-68.34%
logo
Park Dental Partners, Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.30
Actual
$0.56
Surprise
+86.27%
logo
LifeMD, Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.11
Surprise
+23.77%
logo
Ainos, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-
Actual
-$0.25
Surprise
-
logo
Lifeward Ltd. Ordinary Shares
Report Date
Nov 13, 2026 For Q3 26
Estimate
-$0.83
Actual
-$1.32
Surprise
-57.82%
logo
SeaStar Medical Holding Corporation Common Stock
Report Date
Nov 11, 2026 For Q3 26
Estimate
-$0.93
Actual
-$1.03
Surprise
-10.24%
logo
IceCure Medical Ltd. Ordinary Shares
Report Date
Nov 18, 2026 For Q3 26
Estimate
-$1.18
Actual
-$0.40
Surprise
+66.19%
logo
20/20 Biolabs, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.12
Surprise
+15.97%
FAQ
For Q3 2026, Organon & Co. reported EPS of $0.94, missing estimates by -0.73%, and revenue of $1.57B, -1.03% below expectations.
The stock price moved up 0.22%, changed from $13.81 before the earnings release to $13.84 the day after.
The next earning report is scheduled for Feb 10, 2027.
Based on -- analysts, Organon & Co. is expected to report EPS of $0.79 and revenue of $1.56B for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement